PAC-3 Lands and Backlog Hits $292 Billion, but the Margin Stays at 10.8%: Maintaining Outperform on Lockheed Martin
Key Takeaways
- Both lines beat and the guide rose for a second quarter, but the margin did not move. Sales of $20,711M beat the $20.48B consensus by 1.1% and EPS of $7.97 beat $7.52 by 6.0%, yet segment margin of 10.76% was 14bps below last year. About $0.20 of the $0.45 beat came from a one-time $40M recovery at Rotary and Mission Systems and a tax rate below Q2's.
- The PAC-3 contract is signed, and Missiles and Fire Control now holds almost half the backlog. A seven-year award worth up to $58.6B added $52.5B, taking backlog to a record $291,984M on a 4x book-to-bill, and MFC grew 24.2% at a 14.0% margin. The 10-Q adds the caveat: only about 23% of backlog converts in the next twelve months, so the near-term book is roughly where it was in June.
- Fixed-price adjustments returned on four programs. The 10-Q implies $170M of unfavourable Q3 adjustments: C-130 $80M, F-16 $45M, Heavy Lift $30M and Seahawk $15M. C-130 has now been cut in every quarter of 2026 and Sikorsky has produced bad news for six straight quarters; without the four programs, segment margin would have been 11.58%.
- F-35 gained a ten-year framework and a near-term funding gap in the same release. The framework sets a path to 850 U.S. aircraft at 156 a year, but Lot 20 slipped into 2027, the Aeronautics profit guide fell $105M at the midpoint, and Lockheed's costs on the Lot 20 advance contract now exceed its funding. Deliveries of 94 through nine months compare with 143 a year ago.
- Rating: Maintaining Outperform, with conviction lowered to 6 from 7. The PAC-3 multi-year was signed inside 2026 and the stock closed below $660, so neither Hold trigger from July was hit, and the free cash flow guide rose $800M. Fair value moves to $611 to $672 on 20x to 22x the $30.55 guidance midpoint, about 6% upside plus a 2.4% dividend, the thinnest cushion since our upgrade.
Results vs. Consensus
Q3 2026 Scorecard
| Metric | Actual | Consensus | Beat/Miss | Magnitude |
|---|---|---|---|---|
| Sales | $20,711M | $20,480M | Beat | +1.1% |
| EPS (GAAP diluted) | $7.97 | $7.52 | Beat | +6.0% |
| Business segment operating profit | $2,229M | n/a | n/a | +9.9% YoY |
| Business segment operating margin | 10.76% | n/a | Flat | -14bps YoY, -1bp QoQ |
| Free cash flow | $2,999M | n/a | n/a | -10.4% YoY, +$82M QoQ |
| Backlog | $291,984M | n/a | Record | +$61,568M QoQ |
| FY2026 guidance | Raised | n/a | Raised | Sales +$250M, EPS +$0.25, FCF +$800M at midpoints |
Unlike the last two quarters, the year-over-year comparison is usable. Q3 2025 carried no reach-forward losses, both periods had thirteen weeks, and the profit lines compare like with like. That makes this the first clean read of underlying margin since our upgrade, and it is less flattering than the headline growth rates.
Year-over-Year Comparison
| Item ($M except per-share) | Q3 2026 | Q3 2025 | Change |
|---|---|---|---|
| Sales | 20,711 | 18,609 | +11.3% |
| Gross profit | 2,436 | 2,240 | +8.8% |
| Gross margin | 11.76% | 12.04% | -28bps |
| Business segment operating profit | 2,229 | 2,029 | +9.9% |
| Business segment operating margin | 10.76% | 10.90% | -14bps |
| Total unallocated items | 214 | 251 | ($37) |
| Consolidated operating profit | 2,443 | 2,280 | +7.1% |
| Consolidated operating margin | 11.80% | 12.25% | -46bps |
| Interest expense | (264) | (286) | -7.7% |
| Non-service FAS pension expense | (81) | (99) | +$18 |
| Other non-operating income, net | 74 | 43 | +$31 |
| Earnings before income taxes | 2,172 | 1,938 | +12.1% |
| Effective tax rate | 15.1% | 16.5% | -140bps |
| Net earnings | 1,845 | 1,619 | +14.0% |
| Diluted EPS | $7.97 | $6.95 | +14.7% |
| Weighted average diluted shares (M) | 231.5 | 232.8 | -0.6% |
| Cash from operations | 3,438 | 3,728 | -7.8% |
| Capital expenditures | (439) | (381) | +15.2% |
| Free cash flow | 2,999 | 3,347 | -10.4% |
Sequential Comparison
| Item ($M except per-share) | Q3 2026 (13 wks) | Q2 2026 (13 wks) | Change |
|---|---|---|---|
| Sales | 20,711 | 20,063 | +3.2% |
| Business segment operating profit | 2,229 | 2,162 | +3.1% |
| Business segment operating margin | 10.76% | 10.78% | -1bp |
| Net earnings | 1,845 | 1,836 | +0.5% |
| Diluted EPS | $7.97 | $7.94 | +0.4% |
| Capital expenditures | 439 | 318 | +$121 |
| Free cash flow | 2,999 | 2,917 | +$82 |
| Total backlog | 291,984 | 230,416 | +$61,568 |
Nine Months 2026
| Item ($M except per-share) | 9M 2026 | 9M 2025 | Change |
|---|---|---|---|
| Sales | 58,795 | 54,727 | +7.4% |
| Business segment operating profit | 6,214 | 4,685 | +32.6% |
| Business segment operating margin | 10.57% | 8.56% | +201bps |
| Net earnings | 5,169 | 3,673 | +40.7% |
| Diluted EPS | $22.36 | $15.69 | +42.5% |
| Cash from operations | 6,893 | 5,338 | +29.1% |
| Capital expenditures | (1,268) | (1,186) | +6.9% |
| Free cash flow | 5,625 | 4,152 | +35.5% |
| Share repurchases | 0 | (2,250) | ($2,250) |
The nine-month profit comparison still carries the 2025 reach-forward losses ($1,615M in Q2 2025), so its growth rates overstate the trend. Quarterly figures tie to the period: $18,021M, $20,063M and $20,711M of sales sum to $58,795M; segment profit of $1,823M, $2,162M and $2,229M sums to $6,214M.
- Sales: Genuine and broad. All four segments grew, MFC by 24.2% and Aeronautics by 13.2%. One item flatters the rate: $270M of C-130 revenue came from liquidating pre-contract costs once the C-130J award arrived, a one-time catch-up. Without it, growth was 9.8%, still the strongest clean rate in our coverage.
- Margins: Flat, and not because the business stood still. Segment margin of 10.76% includes a one-time $40M favourable contract resolution at RMS and absorbs $170M of named unfavourable adjustments. Excluding both, the quarter ran at 11.39%. The reported number is the right one to underwrite, because adjustments have now recurred in all three quarters of 2026.
- EPS: Mixed. Segment profit added $200M year over year, but the beat against the Street leaned on items below segment level: the $40M RMS recovery (about $0.15 a share), a 15.1% tax rate against 15.7% in Q2 (about $0.06) and $31M more other non-operating income. Unallocated costs worked the other way, with "Other, net" rising to ($158M) from ($59M).
- Cash: Strong but partly borrowed from taxes. Free cash flow of $2,999M was down 10.4% against a quarter that had unusually high customer receipts. Nine-month free cash flow of $5,625M is 35.5% higher than last year, helped by a $1,114M deferred-tax add-back (against $72M a year ago) that reflects the new tax law and IRS guidance.
Assessment: revenue. This is the best revenue quarter in our coverage, and the composition is what the thesis needs. MFC added $877M, the fastest growth of any segment, on PAC-3, THAAD, GMLRS and PrSM ramps that management described as running ahead of schedule. Aeronautics added more in dollars, $958M, but $270M of that was a one-time C-130 liquidation and $710M was F-35, whose next lot just slipped a year. The guidance now implies Q4 sales of $22,205M, which is 9.3% higher than last year on fourteen weeks against thirteen and only about 1.5% higher per week. Either the fourth quarter is guided conservatively, as every quarter of 2025 was, or the Lot 20 slip costs more than the release says.
Assessment: margins. The margin line is the disappointment, and it is now measurable on a clean base. Segment margin was 10.90% a year ago and 10.76% this quarter on 11.3% more sales, so the operating leverage the ramp should produce has not appeared. The cause is not MFC dilution: MFC ran at 14.02%, above its 13.8% base. The cause is a recurring layer of adjustments on mature production programs (F-16, C-130, Heavy Lift and Seahawk) worth about 82bps of margin this quarter, partly hidden by a one-time recovery. Guidance holds segment margin at 10.65% for the year, so management is not promising that this changes in 2026.
Assessment: EPS. The $1.02 year-over-year increase is mostly operational. Segment profit rose $200M, while lower interest and pension costs ($40M) and higher non-operating income ($31M) more than covered the $37M increase in unallocated costs. The beat against consensus is lower quality. Around $0.20 of the $0.45 came from the RMS recovery and the tax rate, which leaves an operational beat of roughly $0.25, consistent with the $0.25 guidance raise. Share count contributed only about $0.04, because Lockheed has bought back no stock in 2026 (we cover the reason in Key Topics). The earnings are real, but the quarter did not reveal earnings power above the guide.
Segment Performance
| Segment | Q3 2026 Sales | YoY | Q3 2026 Op Profit | YoY | Q3 2026 Margin | Q3 2025 Margin | Net profit adjustments Q3 26 / Q3 25 |
|---|---|---|---|---|---|---|---|
| Aeronautics | $8,214M | +13.2% | $743M | +8.9% | 9.05% | 9.40% | $35M / $60M |
| Missiles and Fire Control | $4,501M | +24.2% | $631M | +23.7% | 14.02% | 14.07% | $145M / $130M |
| Rotary and Mission Systems | $4,511M | +3.2% | $524M | +3.6% | 11.62% | 11.57% | $110M / $105M |
| Space | $3,485M | +3.8% | $331M | 0.0% | 9.50% | 9.86% | $85M / $70M |
| Total | $20,711M | +11.3% | $2,229M | +9.9% | 10.76% | 10.90% | $375M / $365M |
Net profit booking rate adjustments were $375M company-wide, in line with $365M a year ago and 17% of segment profit. The portfolio is still retiring risk faster than it adds it in aggregate. The problem is concentrated, and the next table shows where.
Fixed-Price Adjustment Tracker
The 10-Q discloses unfavourable adjustments only on a year-to-date basis. Subtracting the six-month figures in the Q2 10-Q gives the quarterly series.
| Program (segment) | Q1 2026 | Q2 2026 | Q3 2026 | 9M 2026 | Stated cause |
|---|---|---|---|---|---|
| C-130 (Aeronautics) | ($55M) | ($40M) | ($80M) | ($175M) | Diminishing manufacturing source integration, delivery delays |
| F-16 (Aeronautics) | ($125M) | $0 | ($45M) | ($170M) | Production performance, development delays |
| Heavy Lift (RMS) | ($95M) in H1 | ($30M) | ($125M) | Production performance | |
| Seahawk (RMS) | ($80M) in H1 | ($15M) | ($95M) | Production performance, schedule delays | |
| Named total | ($395M) in H1 | ($170M) | ($565M) | 9.1% of nine-month segment profit | |
Assessment. All four are production programs, although the F-16 cut also cites development delays on a new configuration. C-130 has been in production for decades and its adjustment grew this quarter, to $80M, in the same quarter it won $4.4B of new orders for 34 aircraft. F-16 is the program management offered in July as proof of resilience after a redesign; it took $45M this quarter. In July we treated this bear point as isolated to Sikorsky. It is not isolated: it spans two segments and four programs, the same breadth we saw in April. The classified programs, where the large losses were, remain quiet.
Backlog by Segment
| Segment | Sept 27, 2026 | June 28, 2026 | QoQ Change | Dec 31, 2025 | YTD Change |
|---|---|---|---|---|---|
| Aeronautics | $57,331M | $54,356M | +$2,975M | $59,435M | ($2,104M) |
| Missiles and Fire Control | $142,517M | $87,882M | +$54,635M | $46,650M | +$95,867M |
| Rotary and Mission Systems | $49,435M | $48,454M | +$981M | $47,715M | +$1,720M |
| Space | $42,701M | $39,724M | +$2,977M | $39,822M | +$2,879M |
| Total | $291,984M | $230,416M | +$61,568M | $193,622M | +$98,362M |
Assessment. MFC backlog has tripled since December and is now 48.8% of the company's total. Total backlog rose 63.1% in a year and covers 3.60 years of guided sales, up from 2.85 years in June. The 10-Q puts the timing in perspective: Lockheed expects to recognise about 23% of backlog in the next twelve months and about 40% within 24 months, against 30% and 50% in June. Applied to the totals, those percentages imply roughly $67B of next-year revenue from backlog, against roughly $69B in June. The PAC-3 award extends the runway; it does not raise 2027.
Missiles and Fire Control: the thesis, now in two signed contracts
MFC sales rose 24.2% to $4,501M on $480M more integrated air and missile defense volume (PAC-3 and THAAD) and $330M more tactical and strike volume (GMLRS and PrSM). Operating profit rose 23.7% to $631M and net profit adjustments improved to $145M from $130M. Margin was 14.02%, down 46bps from Q2's unusually strong 14.48% but still above the 13.8% FY2025 base.
The quarter's defining event was the seven-year PAC-3 contract, which Lockheed booked at $52.5B of a total value up to $58.6B. Full-year MFC guidance rose again, to $17.25B to $17.45B of sales and $2.395B to $2.425B of profit.
"MFC had another very strong quarter as the production ramps on munitions programs progress ahead of schedule."
— Mark Kvasnak, Vice President, Investor Relations
Assessment: In July we named PAC-3 definitization in 2026 as the condition for staying at Outperform, and the seven-year contract was signed one quarter later. MFC now guides to about 20% growth in both sales and profit this year and a 13.89% margin, 13bps above 2025, against a commitment to dilute by no more than 20 to 30 basis points. The one soft spot is the implied fourth quarter: the guide leaves $5,099M of sales and $685M of profit, a 13.43% margin. That is close to the 13.31% of Q4 2025 and may simply be seasonal, but it would be the lowest MFC margin of the year.
Aeronautics: F-35 volume up, everything else down
Aeronautics sales rose 13.2% to $8,214M: $710M from F-35 production and sustainment volume and $270M from the C-130 pre-contract cost liquidation, offset by $130M lower F-16 sales. Operating profit rose 8.9% to $743M, but margin fell 35bps to 9.05% because of higher unfavourable adjustments on F-16 and C-130. F-35 deliveries were 43 against 46, and 94 for nine months against 143.
"We now project Aero to deliver full year 2026 sales of $31.1 billion-$32.5 billion and profits between $2.92 billion and $2.95 billion, slightly lower than our July guidance, driven by revised contract award timing expectations for the next lots of F-35."
— Mark Kvasnak, Vice President, Investor Relations
Assessment: Aeronautics is the only segment whose profit guidance went down, by $105M at the midpoint, and its $400M sales cut is the only material one (RMS tightened its sales range by $50M at the midpoint). The implied fourth quarter is flat on sales against Q4 2025 ($8,521M against $8,524M) despite an extra week. Management says F-35 production is now accretive to segment margin, which matters for the ten-year framework, but the segment is carrying $345M of nine-month adjustments on its two older aircraft lines. A 9.23% guided margin for 2026 is well below the 10% level a question on the call asked about.
Rotary and Mission Systems: a one-time recovery covers the sixth Sikorsky quarter
RMS sales rose 3.2% to $4,511M on $140M more radar volume. Operating profit rose 3.6% to $524M at an 11.62% margin, which looks like a large improvement on Q2's 10.04%. The release explains why: a $40M favourable adjustment on the resolution of a contracting matter offset $45M of unfavourable adjustments on Heavy Lift and Seahawk. Excluding the recovery, margin was 10.73%.
"Segment operating profit finished up 4% year-over-year, benefiting from the favorable resolution of a contracting matter."
— Mark Kvasnak, Vice President, Investor Relations
Assessment: This is the sixth consecutive quarter of negative Sikorsky news, which is the line we said in July would end the "isolated" framing. The quarterly amounts are getting smaller ($45M against $115M in Q2), and the radar business is growing on new awards. But Sikorsky's problem is now one of production performance on two mature programs, not the development charges of 2025. The pending $3.45B Ultra Maritime acquisition will also land in this segment, which adds integration work to a business still fixing its helicopter lines.
Space: growing, with a launch partner that now needs money
Space sales rose 3.8% to $3,485M on $185M more Fleet Ballistic Missile and Next Generation Interceptor volume, partly offset by $115M lower OPIR sales. Operating profit was flat at $331M and margin fell 36bps to 9.50%. Guidance rose to $13.95B to $14.05B of sales and $1.38B to $1.40B of profit.
"To be clear, the profit outlook does not include any ULA equity earnings for the fourth quarter 2026."
— Mark Kvasnak, Vice President, Investor Relations
Assessment: The operating business is fine, and the NGI rocket-motor test keeps a homeland-defense program on track for 2030. The ULA position changed in the 10-Q rather than on the call: Lockheed has now guaranteed up to $750M of ULA borrowings and says it and Boeing expect to provide further financial support. That converts a drag on equity earnings into a cash obligation, which we cover below.
Key KPIs
| KPI | Q3 2026 | Q2 2026 | Q3 2025 | 9M 2026 | 9M 2025 |
|---|---|---|---|---|---|
| F-35 deliveries | 43 | 19 | 46 | 94 | 143 |
| F-16 deliveries | 4 | 2 | 5 | 6 | 12 |
| C-130J deliveries | 2 | 7 | 0 | 10 | 2 |
| Government helicopter deliveries | 16 | n/a | 22 | 51 | 55 |
| Book-to-bill | ~4.0x | 3.2x | n/a | n/a | n/a |
| Independent research and development | $599M | n/a | n/a | ~$1.6B | n/a |
| Capital expenditures | $439M | $318M | $381M | $1,268M | $1,186M |
| Net profit booking rate adjustments | $375M | $375M | $365M | $965M | ($200M) |
Key Topics & Management Commentary
Overall Management Tone: Confident and expansive, but less precise than in July. Management spent most of the prepared remarks on speed, integration and new products, and very little on the items that moved the numbers: the four programs with adjustments got one sentence, F-35 deliveries got none, and the ULA guarantee appeared only in the 10-Q. The financial answers were specific where the news was good (PAC-3, cash, 2027 growth) and general where it was not.
1. The PAC-3 contract and what $292 billion of backlog actually buys
The seven-year PAC-3 contract is the second munitions multi-year of 2026, after THAAD in Q2, and the largest award in our coverage. Book-to-bill was 4x and backlog rose $113B in a year.
"The largest contributor in the quarter was the PAC-3 seven-year contract, which brings that multi-year contract to a total value of up to $58.6 billion."
— Evan Scott, Chief Financial Officer
Management also said that "much of next year's work" is already under contract, without quantifying it. The 10-Q quantifies it: about 23% of backlog in twelve months, roughly the same dollar amount as at the end of June.
Assessment: The thesis was built on the munitions franchise moving from forecast to contract, and with THAAD and PAC-3 both signed, it has. What investors should not do is read the backlog jump as a 2027 revenue signal. The PAC-3 award is long-dated, and the near-term book is flat, which is consistent with management's "high single-digit" 2027 growth rather than anything faster. The value of this quarter's bookings is duration and visibility, and that is a multiple argument, not an estimate argument.
2. What is signed, and what is still being negotiated
Asked how the munitions agreements work, management described four provisions: seven-year terms (ten for F-35), an annual inflation escalator from a year-zero price with no annual cost repricing, cash neutrality during the investment phase, and a recovery mechanism if a future government cuts volumes or duration. The last of these is the clawback protection described in April, now explained in full.
"What is left to work is the finalization on the profit terms and on the schedule itself, noting that the schedule is fluid because both we and the department are making investments to scale the production, and we are seeing that."
— Evan Scott, Chief Financial Officer
The CEO set a floor on what Lockheed will accept.
"We are not going to enter into these agreements if we cannot get at or better financial outcomes than in the past."
— Jim Taiclet, Chairman, President and Chief Executive Officer
Assessment: This is the most important qualification of the quarter. Volume, duration, cash terms and budget protection are agreed; on the CFO's account, the profit terms are not. The answer did not separate the signed PAC-3 and THAAD multi-years from the PrSM and JATM frameworks that are not yet contracts, and neither the release nor the 10-Q calls the multi-years definitized. Our July note called THAAD "definitized"; until the company says so, we treat the profit terms on the munitions book as open. The CEO's floor ("at or better" than the cost-accounting system) is a strong public commitment, and MFC's 14% margin under these arrangements supports it. But we cannot yet show that the margin on $142.5B of MFC backlog is contractually fixed, and that is a risk we did not price in July.
3. Capacity: more partners, more floor space, the same capital envelope
Lockheed placed large supplier contracts to match the multi-years: $4.7B with L3Harris for PAC-3 propulsion in the quarter, and after quarter end $14.7B with Boeing to triple PAC-3 seeker production and $1.6B with Northrop Grumman. It is adding 2 million square feet across eight sites over three years and hiring more than 3,000 people at MFC this year.
"All of this is part of more than the $8 billion investment we are making through 2030 to modernize more than 20 facilities, expand our supply chain, and grow our workforce."
— Jim Taiclet, Chairman, President and Chief Executive Officer
The CEO also cited a GM Defense contract that delivered PAC-3 components within a month "without an increase in our own capital investment," and a Hadrian automated machining cell supplied as manufacturing-as-a-service at the expanded Grand Prairie site.
Assessment: Two things changed in the description. The program now has an end date (2030), which partly answers the post-2026 schedule we asked for. And the wording moved from "$8 billion to $9 billion of capital" in July to "more than $8 billion" of investment that includes supply chain and workforce. We read that as a broader definition rather than an increase, but it is a looser number than the one we praised in July. Pushing capacity onto suppliers and service contracts keeps Lockheed's own capex flat, at the cost of more dependence on a supply base that, by management's own account, provides about 60% of product content and causes one of its biggest costs when it is late.
4. F-35: a ten-year framework and a Lot 20 funding gap
On the morning of the call the Department of War announced a framework agreement for F-35 production and sustainment over ten years.
"This agreement solidifies the path to 850 U.S. aircraft over a 10-year span, which will be further augmented by sales to our allies, achieving a total production at 156 aircraft per year for 10 years."
— Jim Taiclet, Chairman, President and Chief Executive Officer
The release and 10-Q carry the other half. Lockheed is still negotiating Lot 20 and later lots, and its costs on the Lot 20 advance acquisition contract "began to exceed the current contractual authorization and funding" during the quarter. Without more authorization and funding, results, cash flow and financial condition "will be negatively impacted in future periods." Management moved the Lot 20 award assumption to 2027.
Assessment: The framework is the most important long-term event for the F-35 since the program entered full-rate production: ten years of stable volume is what lets suppliers invest, and the CEO wants to use it to add sixth-generation technology at a fraction of a new aircraft's cost. The near-term mechanics are the opposite. Lockheed is again funding F-35 work ahead of a contract, as it did before Lots 18 and 19, and the release does not size the exposure. A framework is not a contract, and the cash drag that the Lot 18/19 award released in late 2025 can come back if Lot 20 slides further.
5. Aeronautics guidance cut and the older aircraft lines
The Aeronautics cut is entirely the F-35 timing assumption, according to management. The adjustments on F-16 and C-130 received one clause in the prepared remarks.
"Segment operating profit increased 9% compared to the prior year, as the higher sales volume was partially offset by unfavorable profit adjustments on F-16 and C-130 programs."
— Mark Kvasnak, Vice President, Investor Relations
The 10-Q gives the causes: on F-16, "production performance and development delays"; on C-130, "continued diminishing manufacturing source integration challenges and associated delivery delays." C-130J deliveries fell to two in Q3 from seven in Q2.
Assessment: Three straight quarters of C-130 cuts, rising to $80M, on a line that just won 34 new aircraft, is not a one-off. It suggests the supply-base problem on the C-130 has not been fixed and that the new orders were priced on an estimate the program is still not meeting. F-16's return after a clean Q2 undercuts the "resilience" argument management made in July. Neither program is large enough to threaten the investment case, but together they explain why Aeronautics margin is below 10% while F-35 production is accretive.
6. Free cash flow raised $800M: collections and tax, not earnings
The free cash flow guide rose to $7.8B to $8.0B from $7.0B to $7.2B, while capex was held at $2.1B to $2.3B and the segment profit guide moved $25M. The whole raise came from cash from operations.
"This is the result of solid collections, improved working capital, and a benefit from continued favorability related to the IRS tax guidance we received earlier this year."
— Evan Scott, Chief Financial Officer
The balance sheet shows the mix: contract assets rose $3,898M in nine months, offset by $1,488M more payables, $1,204M more contract liabilities and $805M lower receivables, and deferred taxes added $1,114M to operating cash.
Assessment: The 2026 cash number is now very good: $7.9B at the midpoint is 14.4% above 2025 with no pension contribution. But almost none of the raise comes from higher profit, and management said the tax benefit will be smaller in 2027, when a pension contribution of more than $1B returns. The free cash flow bear point stays contained for 2026. For 2027, the right expectation is a flat-to-lower number unless the pension is pre-funded this year, which would move cash out of 2026 instead.
7. Capital returns under the executive order
Lockheed has repurchased no stock in 2026, against $2,250M in the first nine months of 2025. The board raised the quarterly dividend 4.3% to $3.60, the 24th consecutive annual increase. Management stated its capital priorities in the usual order.
"Our capital deployment priorities remain consistent. First, we invest in the business and in the capacity and innovation that supports long-term growth. Second, we return cash to shareholders."
— Evan Scott, Chief Financial Officer
The context the call did not give is a January 2026 executive order that allows the Secretary of War to identify underperforming defense contractors and, if their remediation plans are judged insufficient, to bar buybacks and dividends in future contracts. Lockheed's 10-Q lists "presidential executive orders" among the risks to share repurchases and dividends. RTX has also made no repurchases in 2026.
Assessment: In April and July we described the missing buyback as management silence. That was incomplete. The more accurate reading is a policy constraint: repurchases carry political risk while the order stands, and dividends have been kept and raised. With $3.45B going to Ultra Maritime in Q4, a possible pension pre-funding and ULA support ahead, we no longer model a buyback in 2027. That makes the per-share algorithm purely operational, which is healthier, but it removes a lever the market used to rely on.
8. ULA becomes a cash question
During the quarter ULA amended its credit agreement, and Lockheed agreed to guarantee borrowings with maximum future principal payments of $750M. The 10-Q states that Lockheed and Boeing "expect to provide additional financial support" and could incur impairment and operating losses if the Vulcan Centaur rocket does not perform as ULA assumes. The carrying value of the investment is $578M.
Assessment: In July we asked whether the 50% ULA stake still earns its place. The answer arrived in a footnote: it now requires a guarantee and further support, and the Space guidance assumes no ULA earnings in Q4. The exposure (a $578M investment plus a $750M guarantee plus undefined support) is small against $292B of backlog, but it is a cash use outside the core business that competes with the buyback, and management did not address it on the call.
9. 2027: high single-digit growth, all four segments
Management declined to give 2027 guidance before January but gave more than usual.
"However, we are comfortable saying that we see all 4 segments growing next year on a top-line basis with the strength of our backlog and demand. And really, when you put it all together, we see clear line of sight to high single-digit revenue growth next year as a company."
— Evan Scott, Chief Financial Officer
Separately, the CFO restated MFC's long-term frame as "mid-teens sales CAGRs over the next 5 years," above the "at least double-digit" framing of January.
Assessment: High single-digit growth from an $81B base is roughly $6B to $7B of new revenue, and it should include the Lot 20 volume that moved out of 2026. Two things will determine what it is worth: whether the segment margin improves from 10.65%, and how much of 2027's growth Ultra Maritime contributes once it closes. We model 8% growth and a 10.8% segment margin, which assumes the adjustment layer shrinks but does not disappear.
10. Budget: a continuing resolution and a reconciliation bill still taking shape
Fiscal 2027 began under a continuing resolution that runs to December 11. The administration's request is a $1.5T defense topline including $350B of mandatory funding through reconciliation, which Congress has not passed.
"Continuing resolutions affect timing and new starts, but they do not change the direction of demand."
— Jim Taiclet, Chairman, President and Chief Executive Officer
Assessment: Management is right that the contracted franchises are protected: undefinitized actions let production start before appropriations, and the multi-years carry recovery mechanisms. The exposure is to new starts (Golden Dome, CCA Increment 2, Vectis' eventual market) and to timing, as the F-35 Lot 20 slip shows. With midterm elections days away, the budget path for 2027 is the largest external variable in the stock, and it is one the company cannot control.
11. Building before the requirement: Vectis and the self-funded pipeline
Lockheed will build five Vectis autonomous aircraft with its own money, aimed at the Air Force's expected CCA Increment 2 competition and designed to be releasable to allies from the start. It also unveiled PAC-3 Edge for the Army's Future Interceptor program, introduced a lower-cost PAC-3 ACE, and won a $1.2B PrSM Increment 2 production contract in the same year as its flight tests.
"This progress gave me confidence to green-light an increase, and now we will build 5 Vectis aircraft with our own investment."
— Jim Taiclet, Chairman, President and Chief Executive Officer
Assessment: The PrSM Increment 2 award is the evidence that this approach pays: development work became production revenue within a year instead of several. Vectis is a larger bet with no contract behind it, and independent research and development of $1.6B in nine months is the cost of these options. We continue to assign them no value until they produce orders, and note that the spending is certain while the revenue is not.
Guidance & Outlook
| Metric | FY2025 actual | July 2026 guide | October 2026 guide | Change at midpoint |
|---|---|---|---|---|
| Net sales | $75,048M | $79,750M – $81,750M | ~$80,000M – $82,000M | Raised $250M |
| Business segment operating profit | $6,743M | $8,500M – $8,700M | ~$8,575M – $8,675M | Raised $25M (narrowed) |
| Total FAS/CAS pension adjustment | $1,123M (adjusted) | ~$1,365M | ~$1,365M | Unchanged |
| Diluted EPS | $21.49 | $29.95 – $30.65 | ~$30.35 – $30.75 | Raised $0.25 |
| Cash from operations | $8,557M | $9,200M – $9,400M | ~$10,000M – $10,200M | Raised $800M |
| Capital expenditures | $1,649M | $2,000M – $2,400M | ~$2,100M – $2,300M | Unchanged (narrowed) |
| Free cash flow | $6,908M | $7,000M – $7,200M | ~$7,800M – $8,000M | Raised $800M |
| Segment (midpoints) | Sales | Change vs July | Op profit | Change vs July | Margin | Implied Q4 margin |
|---|---|---|---|---|---|---|
| Aeronautics | $31,800M | ($400M) | $2,935M | ($105M) | 9.23% | 9.54% |
| Missiles and Fire Control | $17,350M | +$650M | $2,410M | +$85M | 13.89% | 13.43% |
| Rotary and Mission Systems | $17,850M | ($50M) | $1,890M | +$15M | 10.59% | 10.13% |
| Space | $14,000M | +$50M | $1,390M | +$30M | 9.93% | 11.33% |
| Total | $81,000M | +$250M | $8,625M | +$25M | 10.65% | 10.86% |
The segment midpoints sum exactly to the consolidated midpoints. The shape of the raise is the story: $650M of MFC sales offset by a $400M Aeronautics cut, and $130M of profit raises at MFC, RMS and Space offset by $105M at Aeronautics. The incremental margin on the $250M sales raise is 10%, in line with the company average, which is better than July's 2.5%.
What the guide requires in the fourth quarter: $22,205M of sales (+9.3% against Q4 2025, but only about 1.5% more per week given fourteen weeks against thirteen); $2,411M of segment profit at a 10.86% margin, against 10.13% a year ago; $8.19 of EPS, 10.2% above the $7.43 of Q4 2025 excluding the pension settlement; and $2,275M of free cash flow, 17.5% below Q4 2025, with $932M of capex, more than double Q3's spend.
Street at: Consensus entering the print sat at $7.52 for the quarter, and the Street's fourth-quarter EPS estimate was roughly $8.50, above the $8.19 the new midpoint implies. The full-year EPS raise of $0.25 is smaller than the $0.45 quarterly beat, so the guide implicitly trims the fourth quarter against Street expectations.
Guidance style: Conservative, as it has been for five quarters. Lockheed beat every 2025 guided line and has raised twice in 2026. A fourth quarter guided to 1.5% per-week growth, a back-loaded capex number, and a Lot 20 award excluded from every metric all leave room above the midpoint. The one line where we would not assume upside is segment margin, given three quarters of adjustments.
Analyst Q&A Highlights
How much growth sits outside Missiles and Fire Control
The opening question asked management to frame the multi-year growth opportunity in the three segments other than MFC. The answer restated the MFC framework at mid-teens growth for five years, then listed radar awards at RMS, strategic missile defense at Space, and F-35 sustainment and Skunk Works at Aeronautics, without numbers for any of them.
Q: "I mean, in the first one, you mentioned multiple growth drivers outside of MFC, and obviously there is a lot of opportunity and excitement there, but was hoping you could expand on that a little to frame the multi-year growth opportunity in the other segments."
— Gavin Parsons, UBS
A: "Really across the portfolio, we see similar strength, at RMS while we continue to ramp at Sikorsky. We are seeing new strength on the radar business, with key awards that are going to give us some clear line of sight to revenue growth."
— Evan Scott, Chief Financial Officer
Assessment: The quantified part of the answer was MFC, and the rest was qualitative. That matters because MFC is 21% of 2026 guided sales; even at mid-teens growth it adds about three points to company growth, so "high single-digit" 2027 needs the other 79% of the business growing in the mid single digits. The answer suggests it will, but RMS is guided to low single digits this year and Aeronautics to 3% to 7%.
Why the company is building prototypes before requests for proposal
A follow-up asked how a company of Lockheed's size has changed its engineering culture to go from concept to capability in months. The answer described three changes: mission technology roadmaps that cut across the four segments, a model-based digital engineering and production system, and a larger research budget for prototypes built ahead of any government request.
Q: "Then second, in the prepared remarks on going from concept to capability in a very short timeframe. We saw a lot of those examples at AUSA, and just given Lockheed Martin is such a big organization, would love to get any more color on how you are evolving the engineering culture internally."
— Gavin Parsons, UBS
A: "The third thing is increasing the R&D budget to build prototypes based on our expectations through the mission technology roadmaps before any RFI, request for information or request for proposal, comes from the government."
— Jim Taiclet, Chairman, President and Chief Executive Officer
Assessment: The cross-segment "Z-axis" example (an MFC sensor going into the F-22) is the useful detail, because it is a way to win content on existing platforms rather than new ones. The cost is a structurally higher research budget. We regard this as the right strategy for the current customer, and as a risk if the customer reverts to traditional procurement.
Vectis, Skunk Works and the air-combat plan
A question on Vectis and the collaborative combat aircraft market drew the most strategic answer of the call. Management set out a three-part plan for air power: modernize the F-22, stabilize the F-35 under the ten-year framework and add sixth-generation technologies to it, and offer Vectis as the uncrewed third element, releasable to allies from the start.
Q: "Can we talk a bit more about Vectis, and what that means for you guys, CCA, and then just part of a broader question of, what is going on in the Skunk Works, if you can give us a little bit of flavor for that as well."
— Ron Epstein, Bank of America
A: "The second part of the F-35 solution is that will now enable us to add in sixth-generation key technologies and try to get to 80% of what a sixth-generation clean-sheet aircraft would look like at 50% of that clean-sheet aircraft cost."
— Jim Taiclet, Chairman, President and Chief Executive Officer
Assessment: The claim of 80% of a sixth-generation aircraft's capability at half its cost is a direct pitch against a clean-sheet sixth-generation program, and it is the commercial logic behind the ten-year F-35 framework. It is unproven and it will be contested. If the customer accepts it, the F-35 franchise extends well beyond the ten years now framed; if not, Vectis and the F-22 upgrade are the hedges.
What "cash neutral" means in the munitions agreements
A question asked whether cash neutrality means the customer covers Lockheed's capital directly or advances cash that is repaid through unit prices later. The answer was that Lockheed shows the customer its total investment in a line and its suppliers, and the customer keeps the company cash-neutral through the investment phase; cash generation then comes from deliveries. The CEO then walked through the four provisions and the margin floor.
Q: "Evan, I think in the past you have discussed cash flow neutrality. I just wanted to clarify, are you laying capital that is then covered by the customer, or is it that there is an advance that is covered that is then paid back via the unit price down the road?"
— Noah Poponak, Goldman Sachs
A: "We share that with the customer, and the customer ensures that we have the cash neutrality while we are in the investment ramp phase. Then when we get to ramp production, you have the delivery of the products that generate the cash flow."
— Evan Scott, Chief Financial Officer
Assessment: The answer did not say directly whether the advances are recovered in later unit prices, which was the point of the question. The structure described (customer cash during the build, product cash at delivery) is consistent with advances that reverse over the life of the contract, which would make the early-year cash flows look better than the later ones. That is not a problem if disclosed, but it means today's munitions cash flow is not a run rate. The same answer revealed that profit terms are not final.
F-35 margins under the multi-year, and the timing of Lot 20
A two-part question asked how the F-35 framework changes margins across production, sustainment and development, whether Aeronautics can move above a 10% margin, and when Lot 20 will be signed. Management said production is accretive to segment and company margin, that supplier stability is the main source of future gains, and that a Lot 20 signing in 2026 would be upside to all metrics because it is excluded from guidance.
Q: "Would just be interested to see how the F-35 agreement changes the margin profile across production, sustainment and development, and how you think about Aeronautics' ability to expand beyond the 10% margin marker. Just on Lot 20, how do we think about the signing of the agreement and timing there and the margin profile on that specific lot?"
— Sheila Kahyaoglu, Jefferies
A: "When you look at Lot 20, if we do sign a Lot 20 this year, that would represent upside to effectively all our metrics this year. It is not counted on in our guide."
— Evan Scott, Chief Financial Officer
Assessment: No answer was given on the 10% margin question or on the Lot 20 margin. The guidance treatment is prudent, but it sits awkwardly with the 10-Q, which says costs already exceed the Lot 20 funding. Upside if Lot 20 is signed and a negative impact if it is not funded are the same contract seen from two sides, and the size of the exposure between them is undisclosed.
The moving pieces in 2027 free cash flow
A question on 2027 asked about the pension contribution and how much of the cash tax benefit is one-off. Management gave the high single-digit revenue framework, said the tax benefit continues but shrinks, confirmed a 2027 pension contribution above $1B, and said a decision on pre-funding it in 2026 will come before year-end, alongside the all-cash Ultra Maritime closing.
Q: "I was hoping you could touch on some of the 2027 potential moving target, moving pieces, top-line margin, and free cash flow, or at a minimum, on the free cash flow. Evan, if you can speak to, should we expect the billion-dollar pension headwind contribution, and then how much of this raise, related to cash taxes is one-off?"
— Myles Walton, Wolfe Research
A: "And we have talked about a pension contribution in excess of $1 billion to be required next year. We have not made a decision yet if we plan to pre-fund the pension this year based on the strong operational cash we are seeing."
— Evan Scott, Chief Financial Officer
Assessment: This was the most useful financial exchange. It confirms 2027 free cash flow faces a pension headwind of more than $1B and a smaller tax benefit, against a 2026 base flattered by both. No margin answer was given for 2027. We hold our 2027 free cash flow estimate at $7.6B, which is now below the 2026 guide.
Whether demand lasts beyond 2027
The final question asked for a framework for growth after 2027, noting that other primes have described growth beyond next year. The answer was geopolitical rather than financial: adversaries' production rates and objectives require a sustained investment in deterrence.
Q: "I am not asking for guidance or anything like that, but perhaps a conceptual framework for just building comfort that even if things get a little better in 2027, there is sustainability and durability in that growth beyond."
— John Godyn, Citi
A: "It's an unfortunate geopolitical situation that I think will create this sustained demand for many, many years."
— Jim Taiclet, Chairman, President and Chief Executive Officer
Assessment: The financial answer is in the backlog rather than the call: about 60% of $292B sits beyond 24 months, much of it in munitions contracts with recovery provisions. That is a better argument for durability than the geopolitical one, and management did not make it.
What They're NOT Saying
- How much Lockheed is funding on F-35 Lot 20. The 10-Q says costs exceed the authorization and funding on the Lot 20 advance contract and that results "will be negatively impacted" without more funding. Neither the release, the 10-Q nor the call gave a dollar figure, and no analyst asked. Pre-contract costs in inventory rose to $1.9B from $1.5B at year-end, across F-35, F-16, the classified programs and Sikorsky.
- F-35 deliveries. Deliveries of 94 through nine months compare with 143 a year ago, and matching the 156-a-year production rate would require 62 in Q4. The prepared remarks discussed the ten-year framework at length and did not mention 2026 deliveries at all. No 2026 delivery target has been given.
- Why C-130 and F-16 keep slipping. $125M of Q3 adjustments on the two older aircraft lines received one clause on the call and no question in Q&A. There was no remediation plan, no statement on whether the new 34-aircraft C-130J order is priced at the current estimate, and no comment on F-16 after July's "resilience" claim.
- The ULA guarantee. The $750M guarantee and the expectation of further support appear only in the 10-Q. The call mentioned ULA once, to say Q4 Space profit excludes its equity earnings.
- The executive order and the buyback. Nine months of zero repurchases went unmentioned on the call; the 10-Q names presidential executive orders as a risk to repurchases and dividends. Management raised the dividend, kept "return cash to shareholders" as the second priority, and said nothing about whether or when buybacks return.
- When the munitions profit terms will be final. The CFO said profit terms and schedule are still being negotiated but gave no date. With $142.5B of MFC backlog under these arrangements, the timing of final terms matters for the 2027 margin.
- How much of the backlog jump converts soon. Management said "much of next year's work" is already under contract. The 10-Q's percentages show the twelve-month conversion amount was roughly unchanged from June. Management cited the backlog total, not its timing.
Market Reaction
- Pre-print setup: LMT closed at $551.51 on October 21, 18.5% below its $676.70 52-week closing high and 3.0% below where it closed after the July print. The stock was up 14.0% year to date against the S&P 500's 13.3%, up 13.2% over twelve months and up 5.6% over thirty days.
- Reaction session (October 22): The stock gapped up 5.1% to open at $579.51, reached $608.00 intraday (+10.2%), and closed at $589.91, up 7.0% or $38.40.
- Volume: 3.0M shares against a 1.2M thirty-day average, 2.5x normal.
- Benchmark and peers: The S&P 500 fell 1.2%. Other primes rose between 1.6% and 2.7%: Northrop Grumman +2.4%, General Dynamics +1.8%, RTX +1.6% and L3Harris +2.7%.
- Next session (October 23): LMT added 2.4% to close at $604.18 on 1.8M shares while the S&P 500 fell 0.5%, for a two-session gain of 9.6%.
A rerating on duration, not on the quarter. The quarter's earnings did not justify a 9.6% move: EPS beat by $0.45 and the full-year EPS guide rose $0.25. What changed was the visibility. A signed PAC-3 multi-year, a ten-year F-35 framework announced the same morning, a 4x book-to-bill and an $800M free cash flow raise arrived together, and each answered a question that had kept the stock 18.5% below its high. The peer moves suggest roughly two points of the first day was sector sentiment, and the rest was specific to Lockheed.
The fade and the follow-through. The stock gave back $18.09 from its intraday high on the first day, as the margin and Lot 20 details were absorbed, then rose again on the second day against a falling market. That pattern suggests investors weighed the quality questions and decided the backlog and cash outweighed them. At $604.18 the stock trades at 19.8x the 2026 guidance midpoint and is 10.7% below its 52-week closing high.
Street Perspective
Debate: Is the beat good enough when the margin did not improve?
Bull view: The bull case being made on the Street is that a defense prime growing sales 11% with a 4x book-to-bill, raising guidance twice, and lifting free cash flow guidance by $800M is in a different category from the low-single-digit growers it used to be. Margin is a timing issue: ramp revenue books at conservative rates and improves as risk retires.
Bear view: The bear camp contends that the raise is volume and cash rather than margin. Segment margin fell year over year on a clean comparison, the beat leaned on a one-time recovery and the tax rate, unallocated costs rose, and adjustments recurred on four programs. Consensus EPS revisions have drifted down even as revenue estimates rose.
Our take: The bears have the better argument on this quarter and the bulls on the next three years. Ramp economics do not explain the flat margin; the four programs do, and they are mature lines. But MFC, the segment that carries the growth, is at 14% under the new contracts, and its weight in the mix rises every quarter. The margin case now depends on the adjustment layer shrinking, which we will test against the January guide.
Debate: Does the ten-year F-35 framework outweigh the Lot 20 slip?
Bull view: A ten-year framework for 850 U.S. aircraft at 156 a year removes the largest long-term uncertainty in the Aeronautics segment, and management says F-35 production is already margin-accretive. Lot 20 is excluded from guidance, so any 2026 signing is upside.
Bear view: Some sell-side desks argue the framework is not a contract, the near-term mechanics are getting worse, and Lockheed is funding Lot 20 work ahead of authorization again. Deliveries are running 49 below last year, Aeronautics guidance was cut, and the last time Lockheed financed F-35 lots ahead of a contract, the cash stayed tied up for the better part of two years.
Our take: Both are right on different horizons. The framework is worth more to the multiple than the Lot 20 slip is worth to 2026 earnings, which the guide has already absorbed. The risk we would watch is cash: if Lot 20 is not funded by the January print, the working-capital drag that we saw in 2024 could return in 2027, when the pension contribution also does.
Debate: After 9.6% in two days, is the risk/reward still attractive?
Bull view: At 19.8x the 2026 midpoint and about 18x 2027 estimates, with a 5.7% free cash flow yield, a 2.4% dividend, and backlog covering 3.6 years of sales, the stock is still 10.7% below its high. Higher price targets across the Street point to the munitions franchise not being fully priced.
Bear view: The bear camp contends the move has priced the good news. Midterm elections, a continuing resolution and an unpassed reconciliation bill sit in front of 2027, the buyback is constrained by policy, and 2027 free cash flow will fall on the pension contribution. Several desks keep neutral ratings with targets at or below the current price.
Our take: The upside to our fair value midpoint is now about 6%, half what it was in July, so the margin for error is thinner. We stay at Outperform because the next twelve months should roll valuation onto 2027 earnings that grow about 8%, and because the contracted munitions backlog limits the downside from a budget disappointment. If the stock passes $660 without a better margin trajectory, we would move to Hold.
Model Update Needed
| Item | Our prior estimate | Our new estimate | Reason |
|---|---|---|---|
| FY2026 sales | $80,750M | $81,000M | Set at the new guidance midpoint. MFC raise more than offsets the Aeronautics cut; the implied Q4 is conservative on a per-week basis. |
| FY2026 segment operating margin | 10.65% | 10.65% | Unchanged at the guide. Q3's recovery and its adjustments roughly cancel, and we assume no improvement in Q4 beyond the guide. |
| FY2026 diluted EPS | $30.30 | $30.55 | Raised to the new midpoint, which matches the operational part of the Q3 beat. We see upside from a Lot 20 signing but do not model it. |
| FY2026 free cash flow | $7,100M | $7,900M | Raised to the new midpoint on collections and the tax benefit. Excludes any pension pre-funding, which would lower 2026 and raise 2027 by the same amount. |
| FY2026 capital expenditures | $2,200M | $2,200M | Unchanged. Requires $932M in Q4; underspending is upside to free cash flow. |
| Capital returns | ~45% of FCF, buyback resuming modestly in 2027 | Dividends only through 2027 | The executive-order constraint, Ultra Maritime ($3.45B in cash), the pension and ULA support all compete for cash. No buyback modelled in 2026 or 2027. |
| FY2027 sales | ~$85,600M (+6%) | ~$87,500M (+8%) | Raised to management's "high single-digit" framing, including Lot 20 volume moved out of 2026. Excludes Ultra Maritime until it closes. |
| FY2027 segment operating margin | 10.9% | 10.8% | Lowered. Three quarters of adjustments on mature programs argue against assuming the layer disappears. |
| FY2027 diluted EPS | $32.75 | $33.00 | Higher sales, partly offset by the lower margin and the removal of the buyback. Implies 8.0% growth. |
| FY2027 free cash flow | $7,600M | $7,600M | Unchanged, which now means a 3.8% decline from 2026: the pension contribution above $1B returns and the tax benefit shrinks. |
Valuation: We raise our fair value range to $611 to $672 from $606 to $667, holding the 20x to 22x multiple and applying it to the raised $30.55 FY2026 estimate. The midpoint of about $642 implies roughly 6% upside from the $604.18 close, or about 8.6% including the dividend. The midpoint equals 19.4x our FY2027 estimate. We hold the multiple rather than raising it: the PAC-3 contract and the F-35 framework add duration, but the unsettled profit terms, the broader adjustments and the policy limit on buybacks offset it. We will move the valuation basis to FY2027 earnings with January's guidance.
Thesis Scorecard Post-Earnings
| Thesis Point | Status | Notes |
|---|---|---|
| Bull #1: Munitions supercycle drives MFC to a larger share of a higher-margin mix | Confirmed | PAC-3 seven-year contract signed ($52.5B booked of up to $58.6B); MFC backlog $142,517M, 48.8% of the total; sales +24.2% at a 14.02% margin, above the 13.8% base. The caveat is new: management says profit terms on the munitions agreements are still being finalized. Tag holds ON TRACK. |
| Bull #2: F-35 definitization removes the cash drag and firm-fixed-price creates margin opportunity | Challenged | The ten-year framework is the best long-term news the program has had, and production is margin-accretive. But Lot 20 slipped to 2027, costs exceed the Lot 20 funding, the Aeronautics profit guide fell $105M, and deliveries are 94 against 143. The cash half of the pillar is at risk again. Tag moves ON TRACK → AT RISK. |
| Bull #3: Record backlog provides multi-year revenue visibility | Confirmed | $291,984M, up $61,568M on a 4x book-to-bill and covering 3.60 years of guided sales. The added visibility is long-dated: twelve-month conversion is roughly flat at ~$67B. Tag holds ON TRACK. |
| Bear #1: Recurring fixed-price losses are structural, not episodic | Confirmed | $170M of Q3 adjustments on C-130, F-16, Heavy Lift and Seahawk; $565M over nine months; C-130 cut in every quarter of 2026; Sikorsky's sixth straight quarter. No longer isolated to Sikorsky. The classified programs remain clean and company-wide net adjustments are still +$375M. Tag moves EMERGING → MATERIALIZING. |
| Bear #2: Cash conversion is deteriorating and is pre-committed | Challenged | Nine-month free cash flow $5,625M (+35.5%); full-year guide raised $800M to $7.9B. Quality caveat: the raise is collections and tax, and 2027 carries a pension contribution above $1B plus Lot 20 funding risk. Tag holds CONTAINED. |
| Bear #3: Earnings growth is buyback-dependent rather than operational | Neutral | EPS growth is operational, with share count contributing about $0.04. Zero repurchases for nine months, now best explained by the January executive order rather than management choice; dividend raised 4.3%. Tag holds EMERGING, reframed as a policy constraint on capital returns. |
| Bear #4: Capital intensity is structurally higher and forward commitments are unreliable | Neutral | Capex guide held at $2.1B to $2.3B; the program now has an end date ("more than $8 billion" through 2030) but a broader definition than July's "$8 billion to $9 billion of capital." Supplier and service contracts carry more of the capacity. Tag holds CONTAINED. |
Overall: The thesis is unchanged at its center and weaker at its edges. The munitions pillar, which is the reason we own the stock, delivered its last major milestone of 2026 a quarter after THAAD, and the backlog now gives the company three and a half years of visibility. Around that center, two things moved the wrong way: the fixed-price bear point has broadened back to four programs in two segments, and the F-35 pillar has a near-term funding gap that the ten-year framework does not close. Neither is large enough to change the rating; both are reasons to hold it with less conviction.
Action: Maintaining Outperform with a fair value range of $611 to $672, and lowering conviction to 6 from 7. In July we said we would return to Hold above $660 or if PAC-3 definitization slipped past 2026. The PAC-3 multi-year was signed in the third quarter, which meets the substance of that condition even with final profit terms open, and the stock closed at $604.18, so neither trigger was hit. We also said the Sikorsky problem would stop being "isolated" on a sixth quarter of adjustments, and it has, alongside F-16 and C-130. That is the reason for the conviction cut and for the narrower cushion we accept. We now set three Hold triggers: a price above $660 without a better margin path, a fourth consecutive quarter of C-130 or F-16 adjustments in the January print, or a 2027 guide with segment margin below 2026's 10.65%. We would move to Underperform on a reach-forward loss at either classified program, on full-year MFC margin below 13.5% (30bps under the 13.8% base), or on a charge tied to the unfunded Lot 20 work.